Dataset opportunity
Corwave — 医疗影像数据集机会
Corwave 持有的中等规模医疗影像数据集，可用于诊断人工智能和计算机视觉。
Score
68.3
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球医疗影像人工智能市场 = 2024 年为 17.0 亿美元，复合年增长率为 25.8%。
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
医疗影像数据集
Modality
图像
Sector
医疗保健
Volume
中等
Freshness
实时
Rarity
高（专有）
Accessibility
受限
Legal
混合所有权 — GDPR 敏感（个人身份信息审查）
Buyer persona
医疗人工智能与诊断影像公司
Corwave 持有一个专有的医疗影像数据集，该数据集独特地结合了心脏影像与来自其先进心脏泵技术的丰富、纵向的生理信号数据和病历。该多模态数据集涵盖工业、物联网和临床证据，提供了患者心脏功能的全面视图，对于训练和验证用于复杂心血管疾病的高性能诊断人工智能模型具有极高的价值。
尽管由于严格的GDPR和HDS法规以及数据共享所有权存在访问复杂性，但该数据集的价值是巨大的。它直接服务于全球医疗影像人工智能市场，该市场在 2024 年的估值为17.0 亿美元，预计将以25.8% 的复合年增长率爆炸式增长。[1] 这种稀缺性和复杂性意味着，对于具备所需医疗人工智能专业知识的买家来说，该数据集代表着在快速增长的市场中获得竞争优势的关键且稀缺的资产。[1] ⚠ 尽职调查（有价值的数据，可协商的访问权限）：医疗数据受严格的 GDPR 和 HDS（健康数据托管）法规约束；数据所有权在制造商、临床中心和患者之间共享；需要专业医疗人工智能专业知识的高度技术性生理信号数据 · 公司：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
证据共同证明 Corwave 拥有来自临床评估的专有数据集，这些评估针对患有晚期心力衰竭的患者。这一独特的集合结合了医学影像和相应的高分辨率血流动力学传感器数据，直接满足了诊断人工智能开发者的需求。在全球医疗影像人工智能市场预计每年增长超过 25% 的情况下，该数据集提供了构建和验证用于预测患者结局和设备功效的下一代算法所需的稀缺、真实的临床信息。
See dimension details ↓- Training Value84
适用于诊断人工智能
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Dataset Specificity90
主导的“病历”，医疗保健行业，3 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
实时/流式传输
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Buyer Demand90
买家需求异常高，这得益于在预测复合年增长率为 25.8% 的市场中开发先进的人工智能驱动诊断工具的迫切需求。[1]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
个人身份信息/受监管
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
高难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 种证据类型，3 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License28
所有权=混合，许可=GDPR 敏感
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 个数据需求信号（2 种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高 — 专有数据超出已货币化的部分
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit92
✓ 良好目标 — CorWave 是一个良好的目标，因为它是一家临床阶段的医疗设备中小企业，其核心业务是开发物理心脏泵，产生有价值的专有临床前和临床试验数据作为副产品，而它似乎并未将其货币化。问题：该公司仍处于临床/商业前阶段，其主要设备尚未获准商业使用。[4, 18]；其临床前（羊）和即将进行的人体试验的“休眠”数据的确切数量和可访问性尚未确认。[6, 7, 8]
- Deep Qualification80
✓ 通过 — Corwave 是一家临床阶段的医疗设备公司，正在开发一种创新的心脏泵。其临床前和临床试验（影像、生理信号）的数据是宝贵的副产品，但由于与临床中心和患者共享所有权以及严格的 HDS/GDPR 健康数据法规，其商业化过程复杂。
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
IoT / sensor data
这些证据表明来自医疗设备本身的高分辨率时间序列传感器数据，提供了血流和压力等生理背景信息，这对于构建多模态人工智能模型非常有价值。
Medical records / imaging
这证实了来自晚期心力衰竭患者临床评估的专有数据存在，这是任何开发或验证心脏病学诊断人工智能的公司的一项关键资产。
Industrial data
这表明可以获得内部性能数据，将该设备独特的波膜技术与标准泵进行比较，可用于基准测试和解释模型预测。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Corwave Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Medical Imaging market = $1.70 billion in 2024, CAGR 25.8% (source: Global Market Direct). Investment score 68.3/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Konux — 移动遥测数据集机会
View opportunity →工业Filatidrago — 工业运营数据集机会
View opportunity →工业Scale Energy — 维护日志数据集机会
View opportunity →